Luncheons

From Funding to Commercialization: How Regulatory Strategy and Market Access interact

Conference room: Händel-Saal

Why should Regulatory and HTA expectations be aligned early and addressed in parallel during development? How can this dual track approach shape product profiles, de-risk investments, and strengthen partnering prospects?


Furthermore, do Orphan Drugs operate under distinct regulatory frameworks and HTA requirements?

Lectures

Dr. Irina Staatz

Dr. Irina Staatz

Staatz Consulting

Dr. Stefan Blesse

Dr. Stefan Blesse

Granzer Regulatory Consulting & Services

Moderation

Martin Krauss

Martin Krauss

FGK Clinical Research GmbH